
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 06 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 13 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 06 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 13 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="ryychtqa";>1</th>
      <td>Zuniga_2007</td>
      <td>Attenuated measles virus as a vaccine vector</td>
      <td>Zuniga, Armando; Wang, ZiLi; Liniger, Matthias; Hangartner, Lars; Caballero, Michael; Pavlovic, Jovan; Wild, Peter; Viret, Jean Francois; Glueck, Reinhard; Billeter, Martin A.; Naim, Hussein Y.</td>
      <td>2007</td>
      <td>2007-04-20</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707277" target="_blank">PMC3707277</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17303293.0" target="_blank">17303293.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2007.01.064" target="_blank">10.1016/j.vaccine.2007.01.064</a></td>
      <td>ryychtqa</td>
      <td>0.647705</td>
      <td></td>
      <td><a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a></td>
    </tr>
    <tr>
      <th id="u361oua5";>2</th>
      <td>Peruzzi_2009</td>
      <td>A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines</td>
      <td>Peruzzi, Daniela; Dharmapuri, Sridhar; Cirillo, Agostino; Bruni, Bruno Ercole; Nicosia, Alfredo; Cortese, Riccardo; Colloca, Stefano; Ciliberto, Gennaro; La Monica, Nicola; Aurisicchio, Luigi</td>
      <td>2009</td>
      <td>2009-02-25</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115565" target="_blank">PMC7115565</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19162112.0" target="_blank">19162112.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2008.12.051" target="_blank">10.1016/j.vaccine.2008.12.051</a></td>
      <td>u361oua5</td>
      <td>0.627562</td>
      <td><a href="Topic_06.html#hrfbygub">Singh_2016</a>, <a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a>, <a href="Topic_01.html#z2u5frvq">Montefiori_2007</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="ctass7hz";>3</th>
      <td>Bull_2019</td>
      <td>Recombinant vector vaccine evolution</td>
      <td>Bull, James J.; Nuismer, Scott L.; Antia, Rustom</td>
      <td>2019</td>
      <td>2019-07-19</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668849" target="_blank">PMC6668849</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31323032.0" target="_blank">31323032.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pcbi.1006857" target="_blank">10.1371/journal.pcbi.1006857</a></td>
      <td>ctass7hz</td>
      <td>0.626904</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_07.html#neclg3gb">Tripp_2014</a></td>
      <td><a href="Topic_06.html#3vssgben">Bull_2019</a>, <a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a>, <a href="Topic_06.html#ryychtqa">Zuniga_2007</a>, <a href="Topic_02.html#zs8urh6c">Nuismer_2019</a></td>
    </tr>
    <tr>
      <th id="v5n1gupw";>4</th>
      <td>Bangari_2006</td>
      <td>Development of nonhuman adenoviruses as vaccine vectors</td>
      <td>Bangari, Dinesh S.; Mittal, Suresh K.</td>
      <td>2006</td>
      <td>2006-02-13</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462960" target="_blank">PMC1462960</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/16297508.0" target="_blank">16297508.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2005.08.101" target="_blank">10.1016/j.vaccine.2005.08.101</a></td>
      <td>v5n1gupw</td>
      <td>0.622664</td>
      <td><a href="Topic_02.html#aw8p35c5">Tatsis_2004</a></td>
      <td><a href="Topic_02.html#aw8p35c5">Tatsis_2004</a>, <a href="Topic_06.html#mxtry60e">Mittal_2016</a></td>
    </tr>
    <tr>
      <th id="3vssgben";>5</th>
      <td>Bull_2019</td>
      <td>Recombinant vector vaccines and within-host evolution</td>
      <td>James Bull; Scott L. Nuismer; Rustom Antia</td>
      <td>2019</td>
      <td>2019-02-08</td>
      <td>BioRxiv</td>
      <td>N</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1101/545087" target="_blank">10.1101/545087</a></td>
      <td>3vssgben</td>
      <td>0.609826</td>
      <td><a href="Topic_06.html#ctass7hz">Bull_2019</a></td>
      <td><a href="Topic_06.html#ctass7hz">Bull_2019</a>, <a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a>, <a href="Topic_02.html#zs8urh6c">Nuismer_2019</a>, <a href="Topic_06.html#ryychtqa">Zuniga_2007</a></td>
    </tr>
    <tr>
      <th id="s1zl9nbb";>6</th>
      <td>Bishop_1988</td>
      <td>The release into the environment of genetically engineered viruses, vaccines and viral pesticides</td>
      <td>Bishop, David H.L.</td>
      <td>1988</td>
      <td>1988-04-30</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/0169-5347(88)90130-9" target="_blank">10.1016/0169-5347(88)90130-9</a></td>
      <td>s1zl9nbb</td>
      <td>0.597917</td>
      <td><a href="Topic_02.html#lke4y02f">Bishop_1988</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="mxtry60e";>7</th>
      <td>Mittal_2016</td>
      <td>19 Xenogenic Adenoviral Vectors</td>
      <td>Mittal, Suresh K.; Ahi, Yadvinder S.; Vemula, Sai V.</td>
      <td>2016</td>
      <td>2016-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149625" target="_blank">PMC7149625</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/b978-0-12-800276-6.00019-x" target="_blank">10.1016/b978-0-12-800276-6.00019-x</a></td>
      <td>mxtry60e</td>
      <td>0.569062</td>
      <td><a href="Topic_06.html#v5n1gupw">Bangari_2006</a></td>
      <td><a href="Topic_06.html#v5n1gupw">Bangari_2006</a>, <a href="Topic_02.html#u1xbkaq0">Ploquin_2013</a></td>
    </tr>
    <tr>
      <th id="uacon432";>8</th>
      <td>Liniger_2009</td>
      <td>Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses</td>
      <td>Liniger, Matthias; Zuniga, Armando; Morin, Teldja Neige Azzouz; Combardiere, Behazine; Marty, Rene; Wiegand, Marian; Ilter, Orhan; Knuchel, Marlyse; Naim, Hussein Y.</td>
      <td>2009</td>
      <td>2009-05-26</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115622" target="_blank">PMC7115622</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19200842.0" target="_blank">19200842.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2009.01.057" target="_blank">10.1016/j.vaccine.2009.01.057</a></td>
      <td>uacon432</td>
      <td>0.555529</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a>, <a href="Topic_03.html#k785hl1r">Lv_L_2014</a></td>
      <td><a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a>, <a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a>, <a href="Topic_01.html#vct6xakc">Jiang_2006</a>, <a href="Topic_14.html#ngms51ie">Sawada_2011</a></td>
    </tr>
    <tr>
      <th id="zceca4c1";>9</th>
      <td>Roy_S_2007</td>
      <td>Rescue of chimeric adenoviral vectors to expand the serotype repertoire</td>
      <td>Roy, Soumitra; Clawson, David S.; Lavrukhin, Oleg; Sandhu, Arbans; Miller, Jim; Wilson, James M.</td>
      <td>2007</td>
      <td>2007-04-30</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868475" target="_blank">PMC1868475</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17197043.0" target="_blank">17197043.0</a></td>
      <td><a href="https://doi.org/10.1016/j.jviromet.2006.11.022" target="_blank">10.1016/j.jviromet.2006.11.022</a></td>
      <td>zceca4c1</td>
      <td>0.541514</td>
      <td></td>
      <td><a href="Topic_06.html#mxtry60e">Mittal_2016</a>, <a href="Topic_02.html#odeksech">Ertl_2016</a>, <a href="Topic_06.html#v5n1gupw">Bangari_2006</a></td>
    </tr>
    <tr>
      <th id="s27bp7ft";>10</th>
      <td>Bolton_2012</td>
      <td>Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates</td>
      <td>Bolton, Diane L.; Santra, Sampa; Swett-Tapia, Cindy; Custers, Jerome; Song, Kaimei; Balachandran, Harikrishnan; Mach, Linh; Naim, Hussein; Kozlowski, Pamela A.; Lifton, Michelle; Goudsmit, Jaap; Letvin, Norman; Roederer, Mario; Radošević, Katarina</td>
      <td>2012</td>
      <td>2012-09-07</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425710" target="_blank">PMC3425710</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22732429.0" target="_blank">22732429.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2012.06.029" target="_blank">10.1016/j.vaccine.2012.06.029</a></td>
      <td>s27bp7ft</td>
      <td>0.537387</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_01.html#f78ug0c6">Meng_2012</a>, <a href="Topic_01.html#6rcezxjx">Zakhartchouk_2005</a>, <a href="Topic_05.html#ctikde7d">Cervantes-Barragan_2010</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a></td>
    </tr>
    <tr>
      <th id="vr4c59hy";>11</th>
      <td>Xiao_2011</td>
      <td>A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen</td>
      <td>Xiao, Sa; Kumar, Manish; Yang, Xiuli; Akkoyunlu, Mustafa; Collins, Peter L.; Samal, Siba K.; Pal, Utpal</td>
      <td>2011</td>
      <td>2011-07-18</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138909" target="_blank">PMC3138909</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21600949.0" target="_blank">21600949.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2011.05.010" target="_blank">10.1016/j.vaccine.2011.05.010</a></td>
      <td>vr4c59hy</td>
      <td>0.533249</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a>, <a href="Topic_03.html#k785hl1r">Lv_L_2014</a></td>
      <td><a href="Topic_10.html#ovoli9dr">Keshwara_2019</a></td>
    </tr>
    <tr>
      <th id="xaohrtq7";>12</th>
      <td>Lorin_2015</td>
      <td>Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques</td>
      <td>Lorin, Clarisse; Vanloubbeeck, Yannick; Baudart, Sébastien; Ska, Michaël; Bayat, Babak; Brauers, Geoffroy; Clarinval, Géraldine; Donner, Marie-Noëlle; Marchand, Martine; Koutsoukos, Marguerite; Mettens, Pascal; Cohen, Joe; Voss, Gerald</td>
      <td>2015</td>
      <td>2015-04-09</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391709" target="_blank">PMC4391709</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25856308.0" target="_blank">25856308.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0122835" target="_blank">10.1371/journal.pone.0122835</a></td>
      <td>xaohrtq7</td>
      <td>0.505593</td>
      <td><a href="Topic_01.html#5lnehhu1">Mazeike_2012</a></td>
      <td><a href="Topic_06.html#s27bp7ft">Bolton_2012</a>, <a href="Topic_01.html#5hryh1ft">Azizi_2006</a>, <a href="Topic_06.html#270nzddu">Busch_2020</a></td>
    </tr>
    <tr>
      <th id="fie121ns";>13</th>
      <td>White_2018</td>
      <td>Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer</td>
      <td>White, Michael; Freistaedter, Andrew; Jones, Gwendolyn J. B.; Zervos, Emmanuel; Roper, Rachel L.</td>
      <td>2018</td>
      <td>2018-02-23</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825036" target="_blank">PMC5825036</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29474384.0" target="_blank">29474384.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0193131" target="_blank">10.1371/journal.pone.0193131</a></td>
      <td>fie121ns</td>
      <td>0.498469</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="m4sp9sjn";>14</th>
      <td>Matthews_2010</td>
      <td>HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach</td>
      <td>Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Perry, Brian A.; Tsuruta, Yuko; Komarova, Svetlana; Timares, Laura; Zhao, Chunxia; Makarova, Natalia; Borovjagin, Anton V.; Stewart, Phoebe L.; Wu, Hongju; Blackwell, Jerry L.; Curiel, David T.</td>
      <td>2010</td>
      <td>2010-07-27</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910733" target="_blank">PMC2910733</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/20676400.0" target="_blank">20676400.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0011815" target="_blank">10.1371/journal.pone.0011815</a></td>
      <td>m4sp9sjn</td>
      <td>0.495758</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_01.html#vct6xakc">Jiang_2006</a>, <a href="Topic_06.html#hrfbygub">Singh_2016</a></td>
      <td><a href="Topic_06.html#p6ikd8ns">Hansra_2015</a>, <a href="Topic_06.html#u361oua5">Peruzzi_2009</a></td>
    </tr>
    <tr>
      <th id="4mt2v3ip";>15</th>
      <td>Bayer_2011</td>
      <td>Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes</td>
      <td>Bayer, Wibke; Lietz, Ruth; Ontikatze, Teona; Johrden, Lena; Tenbusch, Matthias; Nabi, Ghulam; Schimmer, Simone; Groitl, Peter; Wolf, Hans; Berry, Cassandra M; Überla, Klaus; Dittmer, Ulf; Wildner, Oliver</td>
      <td>2011</td>
      <td>2011-09-26</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193818" target="_blank">PMC3193818</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21943056.0" target="_blank">21943056.0</a></td>
      <td><a href="https://doi.org/10.1186/1742-4690-8-75" target="_blank">10.1186/1742-4690-8-75</a></td>
      <td>4mt2v3ip</td>
      <td>0.491964</td>
      <td><a href="Topic_01.html#vct6xakc">Jiang_2006</a>, <a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_06.html#hrfbygub">Singh_2016</a></td>
      <td><a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a>, <a href="Topic_06.html#s27bp7ft">Bolton_2012</a>, <a href="Topic_01.html#f78ug0c6">Meng_2012</a></td>
    </tr>
    <tr>
      <th id="mu4fdrel";>16</th>
      <td>Meseda_2004</td>
      <td>DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome</td>
      <td>Meseda, Clement A.; Schmeisser, Falko; Pedersen, Robin; Woerner, Amy; Weir, Jerry P.</td>
      <td>2004</td>
      <td>2004-01-05</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/14972567.0" target="_blank">14972567.0</a></td>
      <td><a href="https://doi.org/10.1016/j.virol.2003.09.033" target="_blank">10.1016/j.virol.2003.09.033</a></td>
      <td>mu4fdrel</td>
      <td>0.483117</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="yw8gubcy";>17</th>
      <td>Wang_2010</td>
      <td>Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines</td>
      <td>Wang, Zhongde; Martinez, Joy; Zhou, Wendi; La Rosa, Corinna; Srivastava, Tumul; Dasgupta, Anindya; Rawal, Ravindra; Li, Zhongqui; Britt, William J.; Diamond, Don</td>
      <td>2010</td>
      <td>2010-02-10</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19969118.0" target="_blank">19969118.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2009.11.056" target="_blank">10.1016/j.vaccine.2009.11.056</a></td>
      <td>yw8gubcy</td>
      <td>0.477085</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="3894l9qi";>18</th>
      <td>Fausther-Bovendo_2014</td>
      <td>Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what's important?</td>
      <td>Fausther-Bovendo, Hugues; Kobinger, Gary P</td>
      <td>2014</td>
      <td>2014-11-01</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443060" target="_blank">PMC5443060</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25483662.0" target="_blank">25483662.0</a></td>
      <td><a href="https://doi.org/10.4161/hv.29594" target="_blank">10.4161/hv.29594</a></td>
      <td>3894l9qi</td>
      <td>0.475906</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_06.html#hrfbygub">Singh_2016</a></td>
      <td><a href="Topic_01.html#pr9i9swk">Croyle_2008</a>, <a href="Topic_01.html#eu80ccm6">Pandey_2012</a></td>
    </tr>
    <tr>
      <th id="270nzddu";>19</th>
      <td>Busch_2020</td>
      <td>Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation</td>
      <td>Busch, Elena; Kubon, Kristina D.; Mayer, Johanna K. M.; Pidelaserra-Martí, Gemma; Albert, Jessica; Hoyler, Birgit; Heidbuechel, Johannes P. W.; Stephenson, Kyle B.; Lichty, Brian D.; Osen, Wolfram; Eichmüller, Stefan B.; Jäger, Dirk; Ungerechts, Guy; Engeland, Christine E.</td>
      <td>2020</td>
      <td>2020-02-21</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077255" target="_blank">PMC7077255</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/32098134.0" target="_blank">32098134.0</a></td>
      <td><a href="https://doi.org/10.3390/v12020242" target="_blank">10.3390/v12020242</a></td>
      <td>270nzddu</td>
      <td>0.467243</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a></td>
      <td><a href="Topic_01.html#lcoo85s6">Kim_S_2012</a>, <a href="Topic_05.html#ctikde7d">Cervantes-Barragan_2010</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a></td>
    </tr>
    <tr>
      <th id="p6ikd8ns";>20</th>
      <td>Hansra_2015</td>
      <td>Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion</td>
      <td>Hansra, Satyender; Pujhari, Sujit; Zakhartchouk, Alexander N</td>
      <td>2015</td>
      <td>2015-05-29</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460227" target="_blank">PMC4460227</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26069516.0" target="_blank">26069516.0</a></td>
      <td><a href="https://doi.org/10.2174/1874357901509010001" target="_blank">10.2174/1874357901509010001</a></td>
      <td>p6ikd8ns</td>
      <td>0.466283</td>
      <td></td>
      <td><a href="Topic_06.html#m4sp9sjn">Matthews_2010</a></td>
    </tr>
    <tr>
      <th id="591iufv1";>21</th>
      <td>Babiuk_2000</td>
      <td>Adenoviruses as vectors for delivering vaccines to mucosal surfaces</td>
      <td>Babiuk, L.A; Tikoo, S.K</td>
      <td>2000</td>
      <td>2000-09-29</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126179" target="_blank">PMC7126179</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/11000466.0" target="_blank">11000466.0</a></td>
      <td><a href="https://doi.org/10.1016/s0168-1656(00)00314-x" target="_blank">10.1016/s0168-1656(00)00314-x</a></td>
      <td>591iufv1</td>
      <td>0.447938</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a></td>
      <td><a href="Topic_02.html#b8mfn6o9">Tarahomjoo_2011</a>, <a href="Topic_02.html#aw8p35c5">Tatsis_2004</a>, <a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a></td>
    </tr>
    <tr>
      <th id="cmbg0ty8";>22</th>
      <td>Mühlebach_2016</td>
      <td>Development of Recombinant Measles Virus-Based Vaccines</td>
      <td>Mühlebach, Michael D.; Hutzler, Stefan</td>
      <td>2016</td>
      <td>2016-11-26</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121886" target="_blank">PMC7121886</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28374248.0" target="_blank">28374248.0</a></td>
      <td><a href="https://doi.org/10.1007/978-1-4939-6869-5_9" target="_blank">10.1007/978-1-4939-6869-5_9</a></td>
      <td>cmbg0ty8</td>
      <td>0.447755</td>
      <td></td>
      <td><a href="Topic_06.html#ryychtqa">Zuniga_2007</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a></td>
    </tr>
    <tr>
      <th id="gqqzekfk";>23</th>
      <td>Lin_C_2012</td>
      <td>Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen</td>
      <td>Lin, Chen-Si; Kao, Shih-Han; Chen, Yu-Cheng; Li, Chi-Han; Hsieh, Yuan-Ting; Yang, Shang-Chih; Wu, Chang-Jer; Lee, Ru-Ping; Liao, Kuang-Wen</td>
      <td>2012</td>
      <td>2012-02-03</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298716" target="_blank">PMC3298716</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22304896.0" target="_blank">22304896.0</a></td>
      <td><a href="https://doi.org/10.1186/1480-9222-14-2" target="_blank">10.1186/1480-9222-14-2</a></td>
      <td>gqqzekfk</td>
      <td>0.437763</td>
      <td><a href="Topic_01.html#xv0esvos">Azizi_2005</a>, <a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_06.html#hrfbygub">Singh_2016</a></td>
      <td><a href="Topic_01.html#lbx8tqws">Li_W_2013</a></td>
    </tr>
    <tr>
      <th id="tzq4i5xr";>24</th>
      <td>Bloom_2018</td>
      <td>Immunization by Replication-Competent Controlled Herpesvirus Vectors</td>
      <td>Bloom, David C.; Tran, Robert K.; Feller, Joyce; Voellmy, Richard</td>
      <td>2018</td>
      <td>2018-07-31</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069180" target="_blank">PMC6069180</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29899091.0" target="_blank">29899091.0</a></td>
      <td><a href="https://doi.org/10.1128/jvi.00616-18" target="_blank">10.1128/jvi.00616-18</a></td>
      <td>tzq4i5xr</td>
      <td>0.437112</td>
      <td></td>
      <td><a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a>, <a href="Topic_01.html#qk2ureql">Maunder_2015</a></td>
    </tr>
    <tr>
      <th id="wi7qdbc7";>25</th>
      <td>Lawrence_2013</td>
      <td>Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses</td>
      <td>Lawrence, Tessa M.; Wanjalla, Celestine N.; Gomme, Emily A.; Wirblich, Christoph; Gatt, Anthony; Carnero, Elena; García-Sastre, Adolfo; Lyles, Douglas S.; McGettigan, James P.; Schnell, Matthias J.</td>
      <td>2013</td>
      <td>2013-06-26</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694142" target="_blank">PMC3694142</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23840600.0" target="_blank">23840600.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0067123" target="_blank">10.1371/journal.pone.0067123</a></td>
      <td>wi7qdbc7</td>
      <td>0.435406</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a>, <a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_01.html#vct6xakc">Jiang_2006</a></td>
      <td><a href="Topic_06.html#s27bp7ft">Bolton_2012</a>, <a href="Topic_01.html#vct6xakc">Jiang_2006</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a></td>
    </tr>
    <tr>
      <th id="lke4y02f";>26</th>
      <td>Bishop_1988</td>
      <td>The release into the environment of genetically engineered viruses, vaccines and viral pesticides</td>
      <td>Bishop, David H.L.</td>
      <td>1988</td>
      <td>1988-04-30</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/0167-7799(88)90006-6" target="_blank">10.1016/0167-7799(88)90006-6</a></td>
      <td>lke4y02f</td>
      <td>0.428086</td>
      <td><a href="Topic_06.html#s1zl9nbb">Bishop_1988</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="7a6q4d3h";>27</th>
      <td>Thacker_2009</td>
      <td>Strategies to overcome host immunity to adenovirus vectors in vaccine development</td>
      <td>Thacker, Erin E; Timares, Laura; Matthews, Qiana L</td>
      <td>2009</td>
      <td>2009-06-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700409" target="_blank">PMC3700409</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19485756.0" target="_blank">19485756.0</a></td>
      <td><a href="https://doi.org/10.1586/erv.09.29" target="_blank">10.1586/erv.09.29</a></td>
      <td>7a6q4d3h</td>
      <td>0.422274</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_07.html#fq78593b">Mooney_2013</a></td>
      <td><a href="Topic_02.html#7eqpb7ge">Borovjagin_2014</a>, <a href="Topic_02.html#aw8p35c5">Tatsis_2004</a>, <a href="Topic_06.html#v5n1gupw">Bangari_2006</a></td>
    </tr>
    <tr>
      <th id="dgeisr8h";>28</th>
      <td>Folegatti_2019</td>
      <td>Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine</td>
      <td>Folegatti, Pedro M.; Bellamy, Duncan; Roberts, Rachel; Powlson, Jonathan; Edwards, Nick J.; Mair, Catherine F.; Bowyer, Georgina; Poulton, Ian; Mitton, Celia H.; Green, Nicky; Berrie, Eleanor; Lawrie, Alison M.; Hill, Adrian V.S.; Ewer, Katie J.; Hermon-Taylor, John; Gilbert, Sarah C.</td>
      <td>2019</td>
      <td>2019-05-15</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630572" target="_blank">PMC6630572</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31096710.0" target="_blank">31096710.0</a></td>
      <td><a href="https://doi.org/10.3390/vaccines7020040" target="_blank">10.3390/vaccines7020040</a></td>
      <td>dgeisr8h</td>
      <td>0.420425</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a>, <a href="Topic_01.html#z2u5frvq">Montefiori_2007</a></td>
      <td><a href="Topic_02.html#u1xbkaq0">Ploquin_2013</a>, <a href="Topic_12.html#5zn2vrj5">Warimwe_2013</a></td>
    </tr>
    <tr>
      <th id="bmrfz8pz";>29</th>
      <td>Lopera-Madrid_2017</td>
      <td>Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine</td>
      <td>Lopera-Madrid, Jaime; Osorio, Jorge E.; He, Yongqun; Xiang, Zuoshuang; Adams, L. Garry; Laughlin, Richard C.; Mwangi, Waithaka; Subramanya, Sandesh; Neilan, John; Brake, David; Burrage, Thomas G.; Brown, William Clay; Clavijo, Alfonso; Bounpheng, Mangkey A.</td>
      <td>2017</td>
      <td>2017-03-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112906" target="_blank">PMC7112906</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28241999.0" target="_blank">28241999.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vetimm.2017.01.004" target="_blank">10.1016/j.vetimm.2017.01.004</a></td>
      <td>bmrfz8pz</td>
      <td>0.418540</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_01.html#f78ug0c6">Meng_2012</a>, <a href="Topic_14.html#ngms51ie">Sawada_2011</a>, <a href="Topic_01.html#yk0xxv16">Do_V_2020</a></td>
    </tr>
    <tr>
      <th id="2sg1tlrg";>30</th>
      <td>Clarke_2006</td>
      <td>Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector</td>
      <td>Clarke, David K.; Cooper, David; Egan, Michael A.; Hendry, R. Michael; Parks, Christopher L.; Udem, Stephen A.</td>
      <td>2006</td>
      <td>2006-09-15</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079905" target="_blank">PMC7079905</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/16977404.0" target="_blank">16977404.0</a></td>
      <td><a href="https://doi.org/10.1007/s00281-006-0042-3" target="_blank">10.1007/s00281-006-0042-3</a></td>
      <td>2sg1tlrg</td>
      <td>0.409973</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_12.html#i8xi0h4g">Akahata_2010</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a>, <a href="Topic_01.html#vct6xakc">Jiang_2006</a>, <a href="Topic_10.html#ovoli9dr">Keshwara_2019</a></td>
    </tr>
    <tr>
      <th id="zfuglf2e";>31</th>
      <td>Wyatt_2008</td>
      <td>Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines</td>
      <td>Wyatt, Linda S.; Earl, Patricia L.; Vogt, Jennifer; Eller, Leigh Anne; Chandran, Dev; Liu, Jinyan; Robinson, Harriet L.; Moss, Bernard</td>
      <td>2008</td>
      <td>2008-01-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262837" target="_blank">PMC2262837</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18155813.0" target="_blank">18155813.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2007.11.036" target="_blank">10.1016/j.vaccine.2007.11.036</a></td>
      <td>zfuglf2e</td>
      <td>0.383510</td>
      <td><a href="Topic_01.html#vct6xakc">Jiang_2006</a></td>
      <td><a href="Topic_01.html#8kvs0qw8">Hao_H_2008</a>, <a href="Topic_01.html#d9v2s9o4">Zhang_2011</a></td>
    </tr>
    <tr>
      <th id="axkdf5vu";>32</th>
      <td>Kim_S_2016</td>
      <td>Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines</td>
      <td>Kim, Shin-Hee; Samal, Siba K.</td>
      <td>2016</td>
      <td>2016-07-04</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974518" target="_blank">PMC4974518</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27384578.0" target="_blank">27384578.0</a></td>
      <td><a href="https://doi.org/10.3390/v8070183" target="_blank">10.3390/v8070183</a></td>
      <td>axkdf5vu</td>
      <td>0.383122</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_10.html#ovoli9dr">Keshwara_2019</a>, <a href="Topic_12.html#i8xi0h4g">Akahata_2010</a></td>
    </tr>
    <tr>
      <th id="1x1bnt5j";>33</th>
      <td>Huang_2005</td>
      <td>A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen</td>
      <td>Huang, Chun-Ming; Shi, Zhongkai; DeSilva, Tivanka S.; Yamamoto, Masato; Van Kampen, Kent R.; Elmets, Craig A.; Tang, De-chu C.</td>
      <td>2005</td>
      <td>2005-03-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035721" target="_blank">PMC3035721</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/15717328.0" target="_blank">15717328.0</a></td>
      <td><a href="https://doi.org/10.1002/pmic.200401114" target="_blank">10.1002/pmic.200401114</a></td>
      <td>1x1bnt5j</td>
      <td>0.381976</td>
      <td><a href="Topic_01.html#wxf60gww">Hu_M_2007</a>, <a href="Topic_01.html#8kvs0qw8">Hao_H_2008</a></td>
      <td><a href="Topic_01.html#8kvs0qw8">Hao_H_2008</a></td>
    </tr>
    <tr>
      <th id="vct6xakc";>34</th>
      <td>Jiang_2006</td>
      <td>Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120</td>
      <td>Jiang, Pengfei; Liu, Yanxia; Yin, Xiaolei; Yuan, Fei; Nie, YuChun; Luo, Min; Aihua, Zheng; Liyin, Du; Ding, Mingxiao; Deng, Hongkui</td>
      <td>2006</td>
      <td>2006-01-13</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092882" target="_blank">PMC7092882</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/16313884.0" target="_blank">16313884.0</a></td>
      <td><a href="https://doi.org/10.1016/j.bbrc.2005.11.067" target="_blank">10.1016/j.bbrc.2005.11.067</a></td>
      <td>vct6xakc</td>
      <td>0.380656</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a>, <a href="Topic_01.html#5hryh1ft">Azizi_2006</a>, <a href="Topic_06.html#2sg1tlrg">Clarke_2006</a></td>
    </tr>
    <tr>
      <th id="u8y47qmd";>35</th>
      <td>Fedosyuk_2019</td>
      <td>Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components</td>
      <td>Fedosyuk, Sofiya; Merritt, Thomas; Peralta-Alvarez, Marco Polo; Morris, Susan J; Lam, Ada; Laroudie, Nicolas; Kangokar, Anilkumar; Wright, Daniel; Warimwe, George M; Angell-Manning, Phillip; Ritchie, Adam J; Gilbert, Sarah C; Xenopoulos, Alex; Boumlic, Anissa; Douglas, Alexander D</td>
      <td>2019</td>
      <td>2019-11-08</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949866" target="_blank">PMC6949866</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31047679.0" target="_blank">31047679.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2019.04.056" target="_blank">10.1016/j.vaccine.2019.04.056</a></td>
      <td>u8y47qmd</td>
      <td>0.375573</td>
      <td><a href="Topic_02.html#pnl1acrj">Kopecky-Bromberg_2009</a>, <a href="Topic_07.html#neclg3gb">Tripp_2014</a></td>
      <td><a href="Topic_06.html#v5n1gupw">Bangari_2006</a>, <a href="Topic_02.html#aw8p35c5">Tatsis_2004</a>, <a href="Topic_06.html#489dpefx">Hammond_2005</a></td>
    </tr>
    <tr>
      <th id="hrfbygub";>36</th>
      <td>Singh_2016</td>
      <td>Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines</td>
      <td>Singh, Shakti; Vedi, Satish; Samrat, Subodh Kumar; Li, Wen; Kumar, Rakesh; Agrawal, Babita</td>
      <td>2016</td>
      <td>2016-01-11</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709057" target="_blank">PMC4709057</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26751211.0" target="_blank">26751211.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0146404" target="_blank">10.1371/journal.pone.0146404</a></td>
      <td>hrfbygub</td>
      <td>0.359073</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a></td>
      <td><a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a>, <a href="Topic_12.html#i8xi0h4g">Akahata_2010</a></td>
    </tr>
    <tr>
      <th id="aw8p35c5";>37</th>
      <td>Tatsis_2004</td>
      <td>Adenoviruses as vaccine vectors</td>
      <td>Tatsis, Nia; Ertl, Hildegund C.J.</td>
      <td>2004</td>
      <td>2004-10-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106330" target="_blank">PMC7106330</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/15451446.0" target="_blank">15451446.0</a></td>
      <td><a href="https://doi.org/10.1016/j.ymthe.2004.07.013" target="_blank">10.1016/j.ymthe.2004.07.013</a></td>
      <td>aw8p35c5</td>
      <td>0.354678</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_06.html#v5n1gupw">Bangari_2006</a></td>
      <td><a href="Topic_06.html#v5n1gupw">Bangari_2006</a>, <a href="Topic_06.html#hrfbygub">Singh_2016</a>, <a href="Topic_02.html#7eqpb7ge">Borovjagin_2014</a>, <a href="Topic_06.html#mxtry60e">Mittal_2016</a></td>
    </tr>
    <tr>
      <th id="489dpefx";>38</th>
      <td>Hammond_2005</td>
      <td>Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics</td>
      <td>Hammond, Jef M.; Johnson, Michael A.</td>
      <td>2005</td>
      <td>2005-01-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128824" target="_blank">PMC7128824</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/15683761.0" target="_blank">15683761.0</a></td>
      <td><a href="https://doi.org/10.1016/j.tvjl.2003.09.007" target="_blank">10.1016/j.tvjl.2003.09.007</a></td>
      <td>489dpefx</td>
      <td>0.345603</td>
      <td><a href="Topic_06.html#axkdf5vu">Kim_S_2016</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="v812zn3r";>39</th>
      <td>Saxena_2013</td>
      <td>Pre-existing immunity against vaccine vectors – friend or foe?</td>
      <td>Saxena, Manvendra; Van, Thi Thu Hao; Baird, Fiona J.; Coloe, Peter J.; Smooker, Peter M.</td>
      <td>2013</td>
      <td>2013-01-23</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542731" target="_blank">PMC3542731</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23175507.0" target="_blank">23175507.0</a></td>
      <td><a href="https://doi.org/10.1099/mic.0.049601-0" target="_blank">10.1099/mic.0.049601-0</a></td>
      <td>v812zn3r</td>
      <td>0.344349</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_07.html#neclg3gb">Tripp_2014</a></td>
      <td><a href="Topic_02.html#b8mfn6o9">Tarahomjoo_2011</a>, <a href="Topic_06.html#hrfbygub">Singh_2016</a>, <a href="Topic_01.html#2gt3fwpy">Meseda_2016</a></td>
    </tr>
    <tr>
      <th id="de0b27nq";>40</th>
      <td>Anraku_2008</td>
      <td>Kunjin replicon-based simian immunodeficiency virus gag vaccines</td>
      <td>Anraku, Itaru; Mokhonov, Vladislav V.; Rattanasena, Paweena; Mokhonova, Ekaterina I.; Leung, Jason; Pijlman, Gorben; Cara, Andrea; Schroder, Wayne A.; Khromykh, Alexander A.; Suhrbier, Andreas</td>
      <td>2008</td>
      <td>2008-06-19</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115363" target="_blank">PMC7115363</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18462846.0" target="_blank">18462846.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2008.04.001" target="_blank">10.1016/j.vaccine.2008.04.001</a></td>
      <td>de0b27nq</td>
      <td>0.340714</td>
      <td></td>
      <td><a href="Topic_09.html#0h5vgi5c">Dahiya_2012</a></td>
    </tr>
    <tr>
      <th id="7del8d2p";>41</th>
      <td>Callendret_2007</td>
      <td>Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS</td>
      <td>Callendret, Benoît; Lorin, Valérie; Charneau, Pierre; Marianneau, Philippe; Contamin, Hugues; Betton, Jean-Michel; van der Werf, Sylvie; Escriou, Nicolas</td>
      <td>2007</td>
      <td>2007-07-05</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103356" target="_blank">PMC7103356</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17331558.0" target="_blank">17331558.0</a></td>
      <td><a href="https://doi.org/10.1016/j.virol.2007.01.012" target="_blank">10.1016/j.virol.2007.01.012</a></td>
      <td>7del8d2p</td>
      <td>0.328733</td>
      <td></td>
      <td><a href="Topic_01.html#mghgvr76">Liu_R_2005</a>, <a href="Topic_01.html#ltyqrg81">Escriou_2014</a></td>
    </tr>
    <tr>
      <th id="dqvgng2s";>42</th>
      <td>Ohtsuka_2019</td>
      <td>A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector</td>
      <td>Ohtsuka, Junpei; Fukumura, Masayuki; Furuyama, Wakako; Wang, Shujie; Hara, Kenichiro; Maeda, Mitsuyo; Tsurudome, Masato; Miyamoto, Hiroko; Kaito, Aika; Tsuda, Nobuyuki; Kataoka, Yosky; Mizoguchi, Akira; Takada, Ayato; Nosaka, Tetsuya</td>
      <td>2019</td>
      <td>2019-09-09</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733870" target="_blank">PMC6733870</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31501502.0" target="_blank">31501502.0</a></td>
      <td><a href="https://doi.org/10.1038/s41598-019-49579-y" target="_blank">10.1038/s41598-019-49579-y</a></td>
      <td>dqvgng2s</td>
      <td>0.328249</td>
      <td><a href="Topic_01.html#vct6xakc">Jiang_2006</a>, <a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_01.html#8kvs0qw8">Hao_H_2008</a>, <a href="Topic_04.html#0czzjeop">Chen_2007</a></td>
    </tr>
    <tr>
      <th id="4vkag60z";>43</th>
      <td>Nakayama_2016</td>
      <td>Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens</td>
      <td>Nakayama, Tetsuo; Sawada, Akihito; Yamaji, Yoshiaki; Ito, Takashi</td>
      <td>2016</td>
      <td>2016-01-04</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115616" target="_blank">PMC7115616</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26562316.0" target="_blank">26562316.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2015.10.127" target="_blank">10.1016/j.vaccine.2015.10.127</a></td>
      <td>4vkag60z</td>
      <td>0.325056</td>
      <td><a href="Topic_07.html#fq78593b">Mooney_2013</a></td>
      <td><a href="Topic_14.html#ngms51ie">Sawada_2011</a>, <a href="Topic_06.html#cmbg0ty8">Mühlebach_2016</a>, <a href="Topic_01.html#3qdjmb2j">Mok_H_2012</a></td>
    </tr>
    <tr>
      <th id="tjvjlyn9";>44</th>
      <td>Luke_2010</td>
      <td>Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers</td>
      <td>Luke, J M; Vincent, J M; Du, S X; Gerdemann, U; Leen, A M; Whalen, R G; Hodgson, C P; Williams, J A</td>
      <td>2010</td>
      <td>2010-11-25</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091570" target="_blank">PMC7091570</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21107439.0" target="_blank">21107439.0</a></td>
      <td><a href="https://doi.org/10.1038/gt.2010.149" target="_blank">10.1038/gt.2010.149</a></td>
      <td>tjvjlyn9</td>
      <td>0.320161</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="a3nzj6yh";>45</th>
      <td>Zhang_2016</td>
      <td>Adenoviral vector-based strategies against infectious disease and cancer</td>
      <td>Zhang, Chao; Zhou, Dongming</td>
      <td>2016</td>
      <td>2016-04-22</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994731" target="_blank">PMC4994731</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27105067.0" target="_blank">27105067.0</a></td>
      <td><a href="https://doi.org/10.1080/21645515.2016.1165908" target="_blank">10.1080/21645515.2016.1165908</a></td>
      <td>a3nzj6yh</td>
      <td>0.305064</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a>, <a href="Topic_02.html#aw8p35c5">Tatsis_2004</a>, <a href="Topic_07.html#fq78593b">Mooney_2013</a></td>
      <td><a href="Topic_02.html#aw8p35c5">Tatsis_2004</a>, <a href="Topic_02.html#7eqpb7ge">Borovjagin_2014</a>, <a href="Topic_02.html#odeksech">Ertl_2016</a></td>
    </tr>
    <tr>
      <th id="l3ej1hdk";>46</th>
      <td>Patel_2010</td>
      <td>A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model</td>
      <td>Patel, Ami; Tikoo, Suresh; Kobinger, Gary</td>
      <td>2010</td>
      <td>2010-12-16</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002947" target="_blank">PMC3002947</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21179494.0" target="_blank">21179494.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0015301" target="_blank">10.1371/journal.pone.0015301</a></td>
      <td>l3ej1hdk</td>
      <td>0.304688</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a></td>
      <td><a href="Topic_01.html#f78ug0c6">Meng_2012</a>, <a href="Topic_12.html#5zn2vrj5">Warimwe_2013</a>, <a href="Topic_07.html#xdpajuit">Wu_P_2017</a></td>
    </tr>
    <tr>
      <th id="7mi07qm9";>47</th>
      <td>Hangalapura_2012</td>
      <td>CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic</td>
      <td>Hangalapura, Basav N.; Timares, Laura; Oosterhoff, Dinja; Scheper, Rik J.; Curiel, David T.; de Gruijl, Tanja D.</td>
      <td>2012</td>
      <td>2012-06-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433169" target="_blank">PMC3433169</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22228547.0" target="_blank">22228547.0</a></td>
      <td><a href="https://doi.org/10.1002/jgm.1648" target="_blank">10.1002/jgm.1648</a></td>
      <td>7mi07qm9</td>
      <td>0.304020</td>
      <td><a href="Topic_01.html#z2u5frvq">Montefiori_2007</a></td>
      <td><a href="Topic_05.html#tkzwzc57">Garu_2016</a>, <a href="Topic_05.html#ctikde7d">Cervantes-Barragan_2010</a></td>
    </tr>
    <tr>
      <th id="tbp3it7r";>48</th>
      <td>Liniger_2008</td>
      <td>Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses</td>
      <td>Liniger, Matthias; Zuniga, Armando; Tamin, Azaibi; Azzouz-Morin, Teldja N.; Knuchel, Marlyse; Marty, Rene R.; Wiegand, Marian; Weibel, Sara; Kelvin, David; Rota, Paul A.; Naim, Hussein Y.</td>
      <td>2008</td>
      <td>2008-04-16</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115634" target="_blank">PMC7115634</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18346823.0" target="_blank">18346823.0</a></td>
      <td><a href="https://doi.org/10.1016/j.vaccine.2008.01.057" target="_blank">10.1016/j.vaccine.2008.01.057</a></td>
      <td>tbp3it7r</td>
      <td>0.300148</td>
      <td><a href="Topic_07.html#nzuq0dk7">Schwartz_2007</a>, <a href="Topic_03.html#k785hl1r">Lv_L_2014</a></td>
      <td><a href="Topic_01.html#ltyqrg81">Escriou_2014</a></td>
    </tr>
  </tbody>
</table>
</body>
</html>
